Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Diagnostic Radiopharmaceuticals Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Diagnostic Radiopharmaceuticals Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Diagnostic Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Type
    • 1.4.2 Tc-99m
    • 1.4.3 F-18
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Diagnostic Radiopharmaceuticals Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Cardiology
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Diagnostic Radiopharmaceuticals Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Diagnostic Radiopharmaceuticals Industry
      • 1.6.1.1 Diagnostic Radiopharmaceuticals Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Diagnostic Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Diagnostic Radiopharmaceuticals Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
    • 2.1.1 Global Diagnostic Radiopharmaceuticals Revenue 2015-2026
    • 2.1.2 Global Diagnostic Radiopharmaceuticals Sales 2015-2026
  • 2.2 Diagnostic Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Diagnostic Radiopharmaceuticals Competitor Landscape by Players

  • 3.1 Diagnostic Radiopharmaceuticals Sales by Manufacturers
    • 3.1.1 Diagnostic Radiopharmaceuticals Sales by Manufacturers (2015-2020)
    • 3.1.2 Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Diagnostic Radiopharmaceuticals Revenue by Manufacturers
    • 3.2.1 Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
    • 3.2.2 Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Diagnostic Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Diagnostic Radiopharmaceuticals Revenue in 2019
    • 3.2.5 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Diagnostic Radiopharmaceuticals Price by Manufacturers
  • 3.4 Diagnostic Radiopharmaceuticals Manufacturing Base Distribution, Product Types
    • 3.4.1 Diagnostic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Diagnostic Radiopharmaceuticals Product Type
    • 3.4.3 Date of International Manufacturers Enter into Diagnostic Radiopharmaceuticals Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Diagnostic Radiopharmaceuticals Market Size by Type (2015-2020)
    • 4.1.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2015-2020)
    • 4.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2015-2020)
    • 4.1.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
    • 4.2.3 Diagnostic Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Diagnostic Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Diagnostic Radiopharmaceuticals Market Size by Application (2015-2020)
    • 5.1.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2015-2020)
    • 5.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2015-2020)
    • 5.1.3 Diagnostic Radiopharmaceuticals Price by Application (2015-2020)
  • 5.2 Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Diagnostic Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Diagnostic Radiopharmaceuticals by Country
    • 6.1.1 North America Diagnostic Radiopharmaceuticals Sales by Country
    • 6.1.2 North America Diagnostic Radiopharmaceuticals Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Type
  • 6.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Diagnostic Radiopharmaceuticals by Country
    • 7.1.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
    • 7.1.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Type
  • 7.3 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Diagnostic Radiopharmaceuticals by Region
    • 8.1.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
    • 8.1.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Type
  • 8.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Diagnostic Radiopharmaceuticals by Country
    • 9.1.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country
    • 9.1.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Diagnostic Radiopharmaceuticals Market Facts & Figures by Type
  • 9.3 Central & South America Diagnostic Radiopharmaceuticals Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Diagnostic Radiopharmaceuticals by Country
    • 10.1.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
    • 10.1.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Type
  • 10.3 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.2 Bayer
    • 11.2.1 Bayer Corporation Information
    • 11.2.2 Bayer Description, Business Overview and Total Revenue
    • 11.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bayer Diagnostic Radiopharmaceuticals Products Offered
    • 11.2.5 Bayer Recent Development
  • 11.3 Curium Pharmaceuticals
    • 11.3.1 Curium Pharmaceuticals Corporation Information
    • 11.3.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.3.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Products Offered
    • 11.3.5 Curium Pharmaceuticals Recent Development
  • 11.4 Nordion
    • 11.4.1 Nordion Corporation Information
    • 11.4.2 Nordion Description, Business Overview and Total Revenue
    • 11.4.3 Nordion Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Nordion Diagnostic Radiopharmaceuticals Products Offered
    • 11.4.5 Nordion Recent Development
  • 11.5 Triad Isotopes
    • 11.5.1 Triad Isotopes Corporation Information
    • 11.5.2 Triad Isotopes Description, Business Overview and Total Revenue
    • 11.5.3 Triad Isotopes Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Triad Isotopes Diagnostic Radiopharmaceuticals Products Offered
    • 11.5.5 Triad Isotopes Recent Development
  • 11.6 Lantheus
    • 11.6.1 Lantheus Corporation Information
    • 11.6.2 Lantheus Description, Business Overview and Total Revenue
    • 11.6.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Lantheus Diagnostic Radiopharmaceuticals Products Offered
    • 11.6.5 Lantheus Recent Development
  • 11.7 GE Healthcare
    • 11.7.1 GE Healthcare Corporation Information
    • 11.7.2 GE Healthcare Description, Business Overview and Total Revenue
    • 11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 GE Healthcare Diagnostic Radiopharmaceuticals Products Offered
    • 11.7.5 GE Healthcare Recent Development
  • 11.8 China Isotope & Radiation
    • 11.8.1 China Isotope & Radiation Corporation Information
    • 11.8.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.8.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Products Offered
    • 11.8.5 China Isotope & Radiation Recent Development
  • 11.9 Jubilant Pharma
    • 11.9.1 Jubilant Pharma Corporation Information
    • 11.9.2 Jubilant Pharma Description, Business Overview and Total Revenue
    • 11.9.3 Jubilant Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Products Offered
    • 11.9.5 Jubilant Pharma Recent Development
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Corporation Information
    • 11.10.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.10.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Eli Lilly Diagnostic Radiopharmaceuticals Products Offered
    • 11.10.5 Eli Lilly Recent Development
  • 11.1 Bracco Imaging
    • 11.1.1 Bracco Imaging Corporation Information
    • 11.1.2 Bracco Imaging Description, Business Overview and Total Revenue
    • 11.1.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bracco Imaging Diagnostic Radiopharmaceuticals Products Offered
    • 11.1.5 Bracco Imaging Recent Development
  • 11.12 SIEMENS
    • 11.12.1 SIEMENS Corporation Information
    • 11.12.2 SIEMENS Description, Business Overview and Total Revenue
    • 11.12.3 SIEMENS Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 SIEMENS Products Offered
    • 11.12.5 SIEMENS Recent Development
  • 11.13 Dongcheng
    • 11.13.1 Dongcheng Corporation Information
    • 11.13.2 Dongcheng Description, Business Overview and Total Revenue
    • 11.13.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Dongcheng Products Offered
    • 11.13.5 Dongcheng Recent Development
  • 11.14 Navidea
    • 11.14.1 Navidea Corporation Information
    • 11.14.2 Navidea Description, Business Overview and Total Revenue
    • 11.14.3 Navidea Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Navidea Products Offered
    • 11.14.5 Navidea Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region
    • 12.1.1 Global Diagnostic Radiopharmaceuticals Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Diagnostic Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
  • 12.2 North America Diagnostic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.2.1 North America: Diagnostic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.2.2 North America: Diagnostic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.2.3 North America: Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Diagnostic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Diagnostic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.3.2 Europe: Diagnostic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Diagnostic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Diagnostic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Diagnostic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Diagnostic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Diagnostic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Diagnostic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Diagnostic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Diagnostic Radiopharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Diagnostic Radiopharmaceuticals Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Diagnostic Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Diagnostic Radiopharmaceuticals market is segmented into
    Tc-99m
    F-18
    Other

    Segment by Application, the Diagnostic Radiopharmaceuticals market is segmented into
    Oncology
    Cardiology
    Other

    Regional and Country-level Analysis
    The Diagnostic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Diagnostic Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Diagnostic Radiopharmaceuticals Market Share Analysis
    Diagnostic Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diagnostic Radiopharmaceuticals business, the date to enter into the Diagnostic Radiopharmaceuticals market, Diagnostic Radiopharmaceuticals product introduction, recent developments, etc.
    The major vendors covered:
    Bracco Imaging
    Bayer
    Curium Pharmaceuticals
    Nordion
    Triad Isotopes
    Lantheus
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Novartis
    SIEMENS
    Dongcheng
    Navidea

    Buy now